Evidence map›Paper›PMID 8929729›Full record

ArticleEuropean journal of pediatrics1996

Clinical outcome and long-term management of 17 patients with propionic acidaemia.

S B van der Meer, F Poggi, M Spada, J P Bonnefont, H Ogier, P Hubert, E Depondt, D Rapoport, D Rabier, C Charpentier and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Case Report: Novel Mutations in theFrontiers in genetics · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Dietary practices in propionic acidemia: A European survey.Molecular genetics and metabolism reports · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Clinical spectrum of propionic acidaemia.Journal of nutrition and metabolism · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

S B van der MeerHopital Enfants Malades, Unite de metabolisme, Paris, France.
F Poggi
M Spada
J P Bonnefont
H Ogier
P Hubert
E Depondt
D Rapoport
D Rabier
C Charpentier
P Parvy
J Bardet
P Kamoun
J M Saudubray

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledA retrospective study was performed on the clinical outcome and long-term treatment of 17 patients with propionic acidaemia diagnosed during the last 20 years in our hospital. The study group consisted of 12 patients with early onset type of disease and 5 patients with late onset. Seven (41%) patients died, five with early onset and two with late onset. The deceased early onset patients had a median survival of 0.4 years while the deceased late onset patients died at the age of 2.8 and 4 years respectively. Median age of the living early onset patients was 5.2 (1-9.25) years, the late onset patients were 4, 7 and 23 years old. Patients were all treated with natural protein restriction and in most cases carnitine and metronidazole were added. The early onset patients were almost all treated with daily home tube feeding. The mean natural protein intake of early onset patients (6.3 +/- 1.5 g/day) was significantly lower than the natural protein intake of late onset patients (17.6 +/- 5.3 g/day). Supplemental protein intake was higher in early onset patients. The general neurological outcome of our study group was satisfactory with a better outcome for early onset patients. As to growth, many patients showed a failure to thrive, this was particularly for height. The strong protein restriction during the first years of life probably contributed to this.

conclusionThe prognosis for patients with propionic acidaemia appeared to be satisfactory in terms of survival and outcome characteristics such as neurological and mental development. Despite these results the authors feel that the prognosis and quality of life of these patients might be improved with liver transplantation or possibly somatic gene therapy in the future.

Indexed as

Diet, Protein-RestrictedAdolescentAdultAmino Acid Metabolism, Inborn ErrorsCarnitineChildChild, PreschoolFemaleFollow-Up StudiesHumansInfantInfant, NewbornMaleMetronidazoleParenteral Nutrition, HomePropionatesCarnitineMetronidazolePropionates

Identifiers

PMID8929729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.